Logo image of BXC

BLUELINX HOLDINGS INC (BXC) Stock Fundamental Analysis

NYSE:BXC - New York Stock Exchange, Inc. - US09624H2085 - Common Stock - Currency: USD

80.96  +6.58 (+8.85%)

After market: 80.96 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BXC. BXC was compared to 49 industry peers in the Trading Companies & Distributors industry. While BXC has a great health rating, its profitability is only average at the moment. BXC has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BXC had positive earnings in the past year.
BXC had a positive operating cash flow in the past year.
In the past 5 years BXC has always been profitable.
BXC had a positive operating cash flow in each of the past 5 years.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.33%, BXC is in line with its industry, outperforming 44.90% of the companies in the same industry.
Looking at the Return On Equity, with a value of 5.99%, BXC is doing worse than 63.27% of the companies in the same industry.
The Return On Invested Capital of BXC (3.48%) is worse than 69.39% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BXC is in line with the industry average of 9.84%.
The 3 year average ROIC (11.45%) for BXC is well above the current ROIC(3.48%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.33%
ROE 5.99%
ROIC 3.48%
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.89%
ROIC(3y)11.45%
ROIC(5y)14.38%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

The Profit Margin of BXC (1.30%) is worse than 67.35% of its industry peers.
In the last couple of years the Profit Margin of BXC has declined.
BXC has a Operating Margin of 2.39%. This is in the lower half of the industry: BXC underperforms 71.43% of its industry peers.
BXC's Operating Margin has improved in the last couple of years.
BXC has a worse Gross Margin (16.10%) than 87.76% of its industry peers.
BXC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.39%
PM (TTM) 1.3%
GM 16.1%
OM growth 3Y-33.49%
OM growth 5Y28.67%
PM growth 3Y-36.23%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BXC is creating some value.
BXC has less shares outstanding than it did 1 year ago.
BXC has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BXC has been reduced compared to a year ago.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.40 indicates that BXC is not in any danger for bankruptcy at the moment.
BXC has a Altman-Z score (3.40) which is comparable to the rest of the industry.
BXC has a debt to FCF ratio of 14.74. This is a negative value and a sign of low solvency as BXC would need 14.74 years to pay back of all of its debts.
BXC has a Debt to FCF ratio (14.74) which is in line with its industry peers.
BXC has a Debt/Equity ratio of 0.94. This is a neutral value indicating BXC is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.94, BXC is not doing good in the industry: 63.27% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 14.74
Altman-Z 3.4
ROIC/WACC0.36
WACC9.59%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

BXC has a Current Ratio of 4.15. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
BXC has a Current ratio of 4.15. This is amongst the best in the industry. BXC outperforms 89.80% of its industry peers.
A Quick Ratio of 2.73 indicates that BXC has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.73, BXC belongs to the best of the industry, outperforming 87.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.15
Quick Ratio 2.73
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

BXC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -58.89%.
The earnings per share for BXC have been decreasing by -40.26% on average. This is quite bad
The Revenue has decreased by -4.22% in the past year.
BXC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.28% yearly.
EPS 1Y (TTM)-58.89%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-87.38%
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%-2.34%

3.2 Future

BXC is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -11.93% yearly.
BXC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.86% yearly.
EPS Next Y-51.28%
EPS Next 2Y-11.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.73%
Revenue Next 2Y3.86%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2019 2020 2021 2022 2023 2024 2025 2026 0 10 20 30

4

4. Valuation

4.1 Price/Earnings Ratio

BXC is valuated rather expensively with a Price/Earnings ratio of 17.95.
BXC's Price/Earnings ratio is a bit cheaper when compared to the industry. BXC is cheaper than 77.55% of the companies in the same industry.
BXC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.21.
With a Price/Forward Earnings ratio of 16.36, BXC is valued correctly.
Based on the Price/Forward Earnings ratio, BXC is valued a bit cheaper than the industry average as 67.35% of the companies are valued more expensively.
BXC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.70.
Industry RankSector Rank
PE 17.95
Fwd PE 16.36
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BXC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BXC is cheaper than 89.80% of the companies in the same industry.
BXC's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BXC is cheaper than 79.59% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.64
EV/EBITDA 7.02
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

A cheap valuation may be justified as BXC's earnings are expected to decrease with -11.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.93%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BXC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUELINX HOLDINGS INC

NYSE:BXC (7/1/2025, 8:04:01 PM)

After market: 80.96 0 (0%)

80.96

+6.58 (+8.85%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-28 2025-07-28/amc
Inst Owners94.88%
Inst Owner Change6.83%
Ins Owners2.17%
Ins Owner Change0.51%
Market Cap649.30M
Analysts80
Price Target93.08 (14.97%)
Short Float %4.21%
Short Ratio3.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.51%
Min EPS beat(2)0.88%
Max EPS beat(2)16.15%
EPS beat(4)3
Avg EPS beat(4)18.48%
Min EPS beat(4)-4.68%
Max EPS beat(4)61.56%
EPS beat(8)6
Avg EPS beat(8)24.8%
EPS beat(12)9
Avg EPS beat(12)17.26%
EPS beat(16)13
Avg EPS beat(16)31.96%
Revenue beat(2)1
Avg Revenue beat(2)-0.61%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)0.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.39%
Min Revenue beat(4)-2.52%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-3.1%
Revenue beat(12)3
Avg Revenue beat(12)-3.04%
Revenue beat(16)7
Avg Revenue beat(16)1.85%
PT rev (1m)0%
PT rev (3m)-25.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-31.1%
EPS NY rev (1m)0%
EPS NY rev (3m)-24.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.07%
Valuation
Industry RankSector Rank
PE 17.95
Fwd PE 16.36
P/S 0.22
P/FCF 15.64
P/OCF 7.92
P/B 1.02
P/tB 1.17
EV/EBITDA 7.02
EPS(TTM)4.51
EY5.57%
EPS(NY)4.95
Fwd EY6.11%
FCF(TTM)5.18
FCFY6.39%
OCF(TTM)10.22
OCFY12.63%
SpS366.02
BVpS79.3
TBVpS69.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.33%
ROE 5.99%
ROCE 5.2%
ROIC 3.48%
ROICexc 5.21%
ROICexgc 5.72%
OM 2.39%
PM (TTM) 1.3%
GM 16.1%
FCFM 1.41%
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.89%
ROIC(3y)11.45%
ROIC(5y)14.38%
ROICexc(3y)16.19%
ROICexc(5y)17.69%
ROICexgc(3y)17.93%
ROICexgc(5y)19.31%
ROCE(3y)17.1%
ROCE(5y)21.48%
ROICexcg growth 3Y-37.1%
ROICexcg growth 5Y30.12%
ROICexc growth 3Y-37.91%
ROICexc growth 5Y30.01%
OM growth 3Y-33.49%
OM growth 5Y28.67%
PM growth 3Y-36.23%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
F-Score4
Asset Turnover1.8
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 14.74
Debt/EBITDA 5.51
Cap/Depr 106.19%
Cap/Sales 1.38%
Interest Coverage 1.55
Cash Conversion 75.67%
Profit Quality 109.03%
Current Ratio 4.15
Quick Ratio 2.73
Altman-Z 3.4
F-Score4
WACC9.59%
ROIC/WACC0.36
Cap/Depr(3y)107.07%
Cap/Depr(5y)77.02%
Cap/Sales(3y)1.01%
Cap/Sales(5y)0.7%
Profit Quality(3y)260.76%
Profit Quality(5y)177.96%
High Growth Momentum
Growth
EPS 1Y (TTM)-58.89%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-87.38%
EPS Next Y-51.28%
EPS Next 2Y-11.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%-2.34%
Revenue Next Year2.73%
Revenue Next 2Y3.86%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-47.58%
EBIT growth 3Y-41.22%
EBIT growth 5Y31.61%
EBIT Next Year10.48%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-90.66%
FCF growth 3Y-29.89%
FCF growth 5YN/A
OCF growth 1Y-83.17%
OCF growth 3Y-16.31%
OCF growth 5YN/A